Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study-Reference-Cited by-同舟云学术

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

Published:2018-01-15 Issue:1 Volume:50 Page:148-155
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Amoroso Loredana,Erminio Giovanni,Makin Guy,Pearson Andrew D. J.,Brock Penelope,Valteau-Couanet Dominique,Castel Victoria,Pasquet Marlène,Laureys Genevieve,Thomas Caroline,Luksch Roberto,Ladenstein Ruth,Haupt Riccardo,Garaventa Alberto,

Funder

Fondazione Italiana per la Lotta al Neuroblastoma

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2016-511.pdf

Reference25 articles.

1. Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry

2. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

3. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial